Internal Medicine, Endocrinology, Diabetes, & Metabolism · Dubuque, IA
NPI
1811904485
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1000 Langworthy St
Dubuque, IA, 52001
Phone (563) 584-4430
Groups this clinician bills Medicare through
Medicare paid, 2024
$97K
4,453 services
Medicare patients, 2024
387
Average age 72
Drug cost, 2024
$2.2M
9,230 prescriptions
Company payments, 2024
$32.54
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott A Brock was code J0897 (injection, denosumab, 1 mg), 900 times for 11 patients. In total Scott A Brock billed 4,453 services in 71 codes, and Medicare paid $97K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 900 | 11 | $20.69 | $19K |
| 36415 Venipuncture Blood Collection | Office | 434 | 233 | $8.59 | $3,730 |
| 99214 Office E&M - Established | Office | 391 | 195 | $83.38 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 362 | 242 | $11.51 | $4,166 |
| 83036 Blood Count | Office | 273 | 135 | $9.46 | $2,582 |
| 84439 Clinical Chemistry | Office | 203 | 122 | $8.84 | $1,795 |
| 84443 Clinical Chemistry | Office | 203 | 122 | $16.46 | $3,341 |
| 80048 Clinical Chemistry | Office | 137 | 101 | $8.28 | $1,134 |
| 95251 Test - Miscellaneous | Office | 111 | 57 | $23.26 | $2,582 |
| 99213 Office E&M - Established | Office | 103 | 97 | $56.07 | $5,775 |
| 82570 Clinical Chemistry | Office | 98 | 89 | $5.03 | $493 |
| 82043 Clinical Chemistry | Office | 91 | 82 | $5.60 | $510 |
| 82565 Clinical Chemistry | Office | 64 | 58 | $5.02 | $321 |
| 99204 Office E&M - New | Office | 41 | 41 | $101.49 | $4,161 |
| 80061 Clinical Chemistry | Office | 35 | 33 | $12.78 | $447 |
By year: 2022 $102K for 4,207 services; 2023 $119K for 5,408 services; 2024 $97K for 4,453 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 434 | 233 | $8.59 | $3,730 |
| 83036 Blood Count | 273 | 135 | $9.46 | $2,582 |
| 84443 Clinical Chemistry | 203 | 122 | $16.46 | $3,341 |
| 84439 Clinical Chemistry | 203 | 122 | $8.84 | $1,795 |
| 80048 Clinical Chemistry | 137 | 101 | $8.28 | $1,134 |
| 82570 Clinical Chemistry | 98 | 89 | $5.03 | $493 |
| 82043 Clinical Chemistry | 91 | 82 | $5.60 | $510 |
| 82565 Clinical Chemistry | 64 | 58 | $5.02 | $321 |
| 80061 Clinical Chemistry | 35 | 33 | $12.78 | $447 |
| 82306 Clinical Chemistry | 33 | 30 | $28.22 | $931 |
Medicare prescription drug claims, 2024
In 2024, the drug Scott A Brock prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,505 prescriptions and refills. In total Scott A Brock wrote 9,230 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,505 | 2,808 | 253 | $12K |
| Glimepiride Generic | 839 | 2,231 | 240 | $8,310 |
| Metformin Hcl Er Metformin Hcl | 512 | 1,379 | 156 | $5,653 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 452 | 1,158 | 145 | $88K |
| Ozempic Semaglutide | 447 | 576 | 78 | $515K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 426 | 895 | 102 | $286K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 293 | 705 | 96 | $36K |
| Atorvastatin Calcium Generic | 260 | 701 | 72 | $1,884 |
| Methimazole Generic | 238 | 552 | 65 | $2,539 |
| Novolog Flexpen Insulin Aspart | 231 | 470 | 83 | $80K |
| Metformin Hcl Generic | 211 | 604 | 59 | $1,523 |
| Alendronate Sodium Generic | 190 | 426 | 55 | $1,285 |
| Farxiga Dapagliflozin Propanediol | 180 | 297 | 36 | $150K |
| Losartan Potassium Generic | 177 | 442 | 54 | $1,257 |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | 168 | 315 | 53 | $179K |
Brand drugs: 3,890 claims; generic drugs: 4,627 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Scott A Brock $32.54 ($32.54 in general payments such as food, travel and fees) from 2 companies. The largest payer was Medtronic, Inc. with $16.52.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.